glp 1 receptor agonist agent Frontiers GLP-1 Receptor Agonists as Treatments
Description
Safe, drug-free, non-GMO, USA-made
The preliminary data on the effect of GLP-1 RAson asthma in patients with diabetes are promising and merit further trials and research studies.
Key pathways, including Wnt/-catenin, bone morphogenetic protein 2/Smad, phosphoinositide 3-kinase/Akt and protein kinase A, play a role in this
Data Synthesis Twenty-two reports and six prescribing sheets were included
